Eliane Sardh
Stockholm, AB 14186, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Guidelines for the management of acute porphyria: recommendations from the International Porphyria Network.
Journal: The Lancet. Haematology
Published: November 28, 2025
Clinical Characteristics and Outcomes of Acute Intermittent Porphyria: Insights From the European Porphyria Registry.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 26, 2025
Persistent Beetroot Colored Urine in a Three-Year-Old Child: A Case Report.
Journal: Clinical case reports
Published: January 31, 2025
Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension study.
Journal: Orphanet journal of rare diseases
Published: January 25, 2024
Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case-control study of 188 patients.
Journal: Journal of inherited metabolic disease
Published: May 25, 2023
Maternal and fetal outcomes in acute hepatic porphyria: A Swedish National Cohort Study.
Journal: Journal of inherited metabolic disease
Published: January 18, 2023
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals.
Journal: Journal of inherited metabolic disease
Published: October 12, 2022
Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947.
Journal: Cancers
Published: August 23, 2022
Hyperhomocysteinemia in acute hepatic porphyria (AHP) and implications for treatment with givosiran.
Hyperhomocysteinemia in acute hepatic porphyria (AHP) and implications for treatment with givosiran.
Journal: Expert review of gastroenterology & hepatology
Published: August 05, 2022
Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.
Journal: Journal of internal medicine
Published: February 03, 2022
RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria.
Journal: Journal of internal medicine
Published: January 24, 2022
Last Updated: 09/26/2026